25 Results for "

chemotherapy-induced nausea and vomiting

" in MedChemExpress (MCE) Product Catalog:
Products (25)

25 Results for "chemotherapy-induced nausea and vomiting" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-16346
CAS No.: 290297-26-6
Synonyms: CID 6451149
Target:  

Neurokinin Receptor

Netupitant (CID 6451149) is a blood-brain barrier penetrable, orally active NK1 receptor inhibitor with a Ki of 0.95 nM (CHO cells) against the human receptor. Netupitant antagonizes the effects induced by Substance P, inhibits the maximal response of Substance P with a long-lasting action, and suppresses NK1 agonist-induced behaviors in mice and gerbils. Netupitant reduces the frequency of bladder contractions, prolongs contraction intervals, decreases basal pressure at high doses, and acts on the afferent branch of the micturition reflex. Netupitant can be used in research related to overactive bladder, chemotherapy-induced nausea and vomiting, post-operative nausea and vomiting, anxiety disorders, and depression .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-14407A
CAS No.: 265121-04-8
Purity:  98.02%
Synonyms: MK-0517; L785298
Fosaprepitant dimeglumine (MK-0517) is a proagent of Aprepitant (HY-10052). Fosaprepitant dimeglumine is a neurokinin-1 receptor antagonist, which is development for the prevention of chemotherapy-induced nausea and vomiting (CINV) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-116578
CAS No.: 14008-44-7
Purity:  98.03%
Synonyms: EXP999; RP9965
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Metopimazine (EXP999; RP9965) is a phenothiazine, orally available, selective dopamine D2 receptor antagonist that does not penetrate the blood-brain barrier. Metopimazine blocks dopamine D2 receptors in the chemoreceptor trigger zone and the periphery, thereby inhibiting nausea and vomiting. Metopimazine is indicated for chemotherapy-induced nausea and vomiting, and has low central side effects due to its poor brain penetration. The use of metopimazine in acute gastroenteritis may have potential risks .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-A0021
CAS No.: 135729-62-3
Palonosetron hydrochloride is a 5-HT3 antagonist primarily used to prevent acute, delayed, and overall chemotherapy-induced nausea and vomiting. In addition, Palonosetron hydrochloride exhibits moderate anti-flavivirus activity and potent anti-Zika virus activity in mammalian cells. Palonosetron hydrochloride also possesses antidepressant activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0068
CAS No.: 123040-16-4
Synonyms: Y-25130 hydrochloride
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV) .
loading...
    loading...
Cat. No.: HY-B0750
CAS No.: 115956-12-2
Synonyms: MDL-73147
Target:  

5-HT Receptor

Research Areas:  

Cancer

Dolasetron (MDL-73147) is a serotonin 5-HT3 receptor antagonist. Dolasetron acts as an antiemetics agent and can be used for the research of chemotherapy-induced nausea and vomiting in cancer .
loading...
    loading...
Cat. No.: HY-14405A
CAS No.: 414910-30-8
Purity:  99.08%
Synonyms: GW679769B
Casopitant mesylate (GW679769B) is a potent, selective, brain permeable and orally active neurokinin 1 (NK1) receptor antagonist. Casopitant mesylate is a second in the class of antiemetics that acts to antagonise the emetogenic effect of Substance P (HY-P0201). Casopitant mesylate is also a substrate and a weak-to-moderate inhibitor of CYP3A4. Casopitant mesylate can be used for chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV) .
loading...
    loading...
Cat. No.: HY-14407
CAS No.: 172673-20-0
Synonyms: L-758298
Fosaprepitant (L-785298) is a proagent of Aprepitant (HY-10052). Fosaprepitant is a neurokinin-1 receptor antagonist, which is development for the prevention of chemotherapy-induced nausea and vomiting (CINV) .
loading...
    loading...
Cat. No.: HY-14405B
CAS No.: 414910-26-2
Purity:  98.60%
Synonyms: (R)-GW679769
Target:  

Neurokinin Receptor

Research Areas:  

Cancer

(R)-Casopitant ((R)-GW679769) is the isomer of Casopitant (HY-14405). Casopitant is a NK(1)-receptor antagonist. Casopitant can be used for the research of chemotherapy-induced nausea and vomiting .
loading...
    loading...
Cat. No.: HY-A0021S
CAS No.: 1246816-81-8
Palonosetron-d3 hydrochloride is the deuterium labeled Palonosetron hydrochloride (HY-A0021). Palonosetron hydrochloride is a 5-HT3 antagonist primarily used to prevent acute, delayed, and overall chemotherapy-induced nausea and vomiting. In addition, Palonosetron hydrochloride exhibits moderate anti-flavivirus activity and potent anti-Zika virus activity in mammalian cells. Palonosetron hydrochloride also possesses antidepressant activity .
loading...
    loading...
Cat. No.: HY-14407AS
Synonyms: MK-0517-d4; L785298-d4
Fosaprepitant-d4 (dimeglumine) is deuterium labeled Fosaprepitant (dimeglumine). Fosaprepitant dimeglumine (MK-0517) is a proagent of Aprepitant (HY-10052). Fosaprepitant dimeglumine is a neurokinin-1 receptor antagonist, which is development for the prevention of chemotherapy-induced nausea and vomiting (CINV) .
loading...
    loading...
Cat. No.: HY-14407AR
CAS No.: 265121-04-8
Synonyms: MK-0517 (Standard); L785298 (Standard)
Fosaprepitant (dimeglumine) (Standard) is the analytical standard of Fosaprepitant (dimeglumine). This product is intended for research and analytical applications. Fosaprepitant dimeglumine (MK-0517) is a proagent of Aprepitant (HY-10052). Fosaprepitant dimeglumine is a neurokinin-1 receptor antagonist, which is development for the prevention of chemotherapy-induced nausea and vomiting (CINV) .
loading...
    loading...
Cat. No.: HY-A0018
CAS No.: 135729-61-2
Palonosetron is a 5-HT3 antagonist primarily used to prevent acute, delayed, and overall chemotherapy-induced nausea and vomiting. Palonosetron exhibits moderate anti-flavivirus activity and potent anti-Zika virus activity in mammalian cells. Palonosetron also possesses antidepressant activity .
loading...
    loading...
Cat. No.: HY-126161
CAS No.: 16985-03-8
Purity:  99.95%
Synonyms: BRL-4664
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease Cancer

Nonabine (BRL-4664) is an orally active chromenol derivative and Cannabinoid-like antiemetic. Nonabine controls nausea and vomiting induced by cancer chemotherapy regimens. Nonabine can be used in the research of lymphoma and chemotherapy-induced nausea and vomiting .
loading...
    loading...
Cat. No.: HY-14405
CAS No.: 414910-27-3
Synonyms: GW679769
Research Areas:  

Neurological Disease

Casopitant (GW679769) is a potent, selective, brain-penetrant and orally active neurokinin 1 (NK1) receptor antagonist. Casopitant antagonizes the emetic effects of Substance P (HY-P0201). Casopitant is also a substrate and weak to moderate inhibitor of CYP3A4. Casopitant is indicated for chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV) .
loading...
    loading...
Cat. No.: HY-B0019
CAS No.: 123040-69-7
Synonyms: (Rac)-SENS-401 free base
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

Azasetron ((Rac)-SENS-401 free base) is an antiemetic drug with 5-HT3 receptor antagonist activity. Azasetron is often used as a preventive measure for postoperative nausea and vomiting or chemotherapy-induced nausea and vomiting. Azasetron does not impair neutrophil chemotaxis or phagocytosis and does not scavenge O(-)(2) or H(2)O(2) generated by cell-free systems .
loading...
    loading...
Cat. No.: HY-B0068R
CAS No.: 123040-16-4
Research Areas:  

Neurological Disease

Azasetron (hydrochloride) (Standard) is the analytical standard of Azasetron (hydrochloride). This product is intended for research and analytical applications. Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV) .
loading...
    loading...
Cat. No.: HY-B0750S
Synonyms: MDL-73147-d4
Dolasetron (MDL-73147)-d4 is deuterium labeled Dolasetron (HY-B0750). Dolasetron is a serotonin 5-HT3 receptor antagonist. Dolasetron acts as an antiemetics agent and can be used for the research of chemotherapy-induced nausea and vomiting in cancer .
loading...
    loading...
Cat. No.: HY-B0750S1
Synonyms: MDL-73147-d5
Research Areas:  

Cancer

Dolasetron (MDL-73147)-d5 is deuterated labeled Dolasetron (HY-B0750). Dolasetron is a serotonin 5-HT3 receptor antagonist. Dolasetron acts as an antiemetics agent and can be used for the research of chemotherapy-induced nausea and vomiting in cancer .
loading...
    loading...
Cat. No.: HY-143994S
Metopimazine-d6 hydrochloride is the deuterium labeled Metopimazine (HY-116578). Metopimazine (EXP999; RP9965) is a phenothiazine, orally available, selective dopamine D2 receptor antagonist that does not penetrate the blood-brain barrier. Metopimazine blocks dopamine D2 receptors in the chemoreceptor trigger zone and the periphery, thereby inhibiting nausea and vomiting. Metopimazine is indicated for chemotherapy-induced nausea and vomiting, and has low central side effects due to its poor brain penetration. The use of metopimazine in acute gastroenteritis may have potential risks .
loading...
    loading...